蛋白A树脂市场－全球产业规模、份额、趋势、机会和预测，按产品、基质类型、应用（免疫沉淀、抗体纯化）、最终用户、地区和竞争格局划分，2020-2030年预测

2024年全球蛋白A树脂市场规模为13.8亿美元，预计2030年将以10.04%的复合年增长率成长至24.5亿美元。蛋白A树脂是一种亲和层析介质，主要用于从复杂的生物混合物中纯化抗体，特别是免疫球蛋白G，其纯化方法是透过与Fc区特异性结合来实现的。市场扩张的根本驱动力是全球对单株抗体疗法的需求不断增长，尤其是在治疗慢性疾病方面，以及生物製药研发投入的增加。

主要市场驱动因素

单株抗体和生物製剂需求的不断增长显着推动了Protein A树脂市场的发展，因为这些治疗药物需要高效的纯化方法才能满足严格的品质和监管要求。这些药物治疗应用范围的扩大和全球范围内的普及，直接催生了对先进下游加工技术的需求。

主要市场挑战

蛋白A树脂固有的高成本严重阻碍了全球蛋白A树脂市场的扩张。这笔巨额支出构成了相当大的推广门槛，尤其对于预算有限的小型企业和新兴生物製药公司而言更是如此。

主要市场趋势

高容量、耐碱树脂的开发是全球蛋白A树脂市场的一大趋势，它能直接提高纯化效率，并降低生物製药企业的营运成本。这些先进树脂能够更快地处理更多生物製剂，鑑于抗体疗法的需求日益增长，这一点至关重要。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球蛋白A树脂市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 副产品（天然蛋白A、重组蛋白A）
  • 依基质类型（琼脂糖基、玻璃或二氧化硅基、有机聚合物基）
  • 依应用（免疫沉淀（IP）、抗体纯化）
  • 依最终用户（生物製药生产商、临床研究实验室、学术机构）划分
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美蛋白A树脂市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲蛋白A树脂市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区蛋白A树脂市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲蛋白A树脂市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲蛋白A树脂市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球蛋白A树脂市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• GE Healthcare Inc.
• Merck Millipore (Merck KGaA)
• PerkinElmer, Inc.
• GenScript Biotech Corp.
• Agilent Technologies, Inc.
• Repligen Corp.
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Abcam PLC.
• Novasep Holdings SAS

第十六章：策略建议

第17章调查会社について・免责事项

The Global Protein A Resin Market, valued at USD 1.38 Billion in 2024, is projected to experience a CAGR of 10.04% to reach USD 2.45 Billion by 2030. Protein A resin is an affinity chromatography medium primarily used for the purification of antibodies, especially immunoglobulin G, from complex biological mixtures through specific binding to the Fc region. The market's expansion is fundamentally driven by the escalating global demand for monoclonal antibody therapeutics, particularly in treating chronic diseases, and increasing investments in biopharmaceutical research and development.

Key Market Drivers

The increasing demand for monoclonal antibodies and biologics significantly drives the Protein A resin market, as these therapeutics require highly efficient purification methods to meet stringent quality and regulatory guidelines. The expanding therapeutic applications and global adoption of these medicines directly necessitate advanced downstream processing.

Key Market Challenges

The inherently high cost associated with Protein A resins significantly impedes the expansion of the Global Protein A Resin Market. This substantial expenditure acts as a considerable adoption barrier, particularly for smaller entities and emerging biopharmaceutical companies operating with constrained budgets. Such financial pressure compels some manufacturers to explore less efficient, yet more affordable, alternative purification strategies. This decision often compromises the overall yield and purity achievable, thereby directly impacting the quality and cost-effectiveness of the final biologic product.

Key Market Trends

The development of high-capacity and alkali-stable resins represents a significant trend in the Global Protein A Resin Market by directly enhancing purification efficiency and reducing operational costs for biopharmaceutical manufacturers. These advanced resins enable the processing of larger quantities of biologics within shorter timeframes, which is crucial given the increasing demand for antibody therapeutics.

Key Market Players

• GE Healthcare Inc.
• Merck Millipore (Merck KGaA)
• PerkinElmer, Inc.
• GenScript Biotech Corp.
• Agilent Technologies, Inc.
• Repligen Corp.
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• Abcam PLC.
• Novasep Holdings SAS

Report Scope:

In this report, the Global Protein A Resin Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein A Resin Market, By Product:

• Natural Protein A
• Recombinant Protein A

Protein A Resin Market, By Matrix Type:

• Agarose-based
• Glass or Silica Based
• Organic Polymer Based

Protein A Resin Market, By Application:

• Immunoprecipitation (IP)
• Antibody Purification

Protein A Resin Market, By End User:

• Biopharmaceutical Manufacturers
• Clinical Research Laboratories
• Academic Institutes

Protein A Resin Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Protein A Resin Market.

Available Customizations:

Global Protein A Resin Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Protein A Resin Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Natural Protein A, Recombinant Protein A)
  • 5.2.2. By Matrix Type (Agarose-based, Glass or Silica Based, Organic Polymer Based)
  • 5.2.3. By Application (Immunoprecipitation (IP), Antibody Purification)
  • 5.2.4. By End User (Biopharmaceutical Manufacturers, Clinical Research Laboratories, Academic Institutes)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Protein A Resin Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Matrix Type
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Protein A Resin Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Matrix Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Protein A Resin Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Matrix Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Protein A Resin Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Matrix Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Protein A Resin Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Matrix Type
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Protein A Resin Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Matrix Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. France Protein A Resin Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Matrix Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Protein A Resin Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Matrix Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Protein A Resin Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Matrix Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Protein A Resin Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Matrix Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia Pacific Protein A Resin Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Matrix Type
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Protein A Resin Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Matrix Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Protein A Resin Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Matrix Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Protein A Resin Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Matrix Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Protein A Resin Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Matrix Type
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Protein A Resin Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Matrix Type
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. Middle East & Africa Protein A Resin Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Matrix Type
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Protein A Resin Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Matrix Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Protein A Resin Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Matrix Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Protein A Resin Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Matrix Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. South America Protein A Resin Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Matrix Type
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Protein A Resin Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Matrix Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Protein A Resin Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Matrix Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Protein A Resin Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Matrix Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Protein A Resin Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. GE Healthcare Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Merck Millipore (Merck KGaA)
• 15.3. PerkinElmer, Inc.
• 15.4. GenScript Biotech Corp.
• 15.5. Agilent Technologies, Inc.
• 15.6. Repligen Corp.
• 15.7. Thermo Fisher Scientific Inc.
• 15.8. Bio-Rad Laboratories, Inc.
• 15.9. Abcam PLC.
• 15.10. Novasep Holdings SAS

16. Strategic Recommendations

17. About Us & Disclaimer